74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Carl Zeiss Meditec AG
Open
SectorHealthcare
58.45 0.09
Overview
Share price change
24h
Min
57.85
Max
59.2
Income | -45M 16M |
|---|---|
Sales | -89M 491M |
P/E Sector Avg | 31.977 57.333 |
EPS | 0.36 |
Dividend yield | 1.06 |
Profit margin | 3.201 |
Employees | 2,066 |
EBITDA | -41M 37M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +3.4% upside |
Dividend yield Sector Avg | 1.06% 2.63% |
|---|---|
Next Earnings | 13 May 2025 |
Market Cap | -153M 5B |
|---|---|
Previous open | 58.36 |
Previous close | 58.45 |
Technical Score
By Trading Central
Confidence
Bullish Evidence
Carl Zeiss Meditec AG Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Carl Zeiss Meditec AG Forecast
Price Target
By TipRanks
3.4% upside
12 Months Forecast
Average 60.75 EUR 3.4%
High 86.5 EUR
Low 41 EUR
Based on 10 Wall Street analysts offering 12 month price targets forCarl Zeiss Meditec AG - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
